Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 59-65

  Chen, Bertha ^a,b   Wen, Yan ^a   Wang, Hongbo ^a   Polan, Mary Lake ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HH 333300 ^*  (United States)

Author keywords

Estrogen; Fibroblast; Metalloproteinase; Stress urinary incontinence; Tissue inhibitors of metalloproteinase

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME REGULATION; ESTROGEN THERAPY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS INCONTINENCE; URINE INCONTINENCE; VAGINA; WESTERN BLOTTING;

EID: 0038675051     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.378     Document Type: Article

References (27)

1. Thom DH, Brown JS. Reproductive and hormonal risk factors for urinary incontinence in later life: a review of the clinical and epidemiologic literature. J Am Geriatr Soc 1998;46:1411-7.
2. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999;94:66-70.
3. Diokno AC, Brock BM, Brown MB, Herzog AR. Prevalence of urinary incontinence and other urological symptoms in the non-institutionalized elderly. J Urol 1986;136:1022-5.
4. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. BMJ 1980;281:1243-5.
5. Feneley CL, Shepherd AM, Powell PH, Blannin J. Urinary incontinence: prevalence and needs. Br J Urol 1979;51:493-6.
6. Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR. Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 2001;10:785-95.
7. Mokrzycki ML, Mittal K, Smilen SW, Blechman AN, Porges RF, Demopolous RI. Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol 1997;90:402-4.
8. Blakeman PJ, Hilton P, Buhner JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000;86:32-8.
9. Rizk DE, Raaschou T, Mason N, Berg B. Evidence of progesterone receptors in the mucosa of the urinary bladder. Scand J Urol Nephrol 2001;35:305-9.
10. Jackson S, James M, Abrams P. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 2002;109:339-44.
11. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the heart and estrogen/progestin replacement study. Obstet Gynecol 2001;97:116-20.
12. Nimni ME. Collagen: structure, function and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum 1983;13:1-86.
13. Bergman A, Elia G, Cheung D, Perelman N, Nimni ME. Biochemical composition of collagen in continent and stress urinary incontinent women. Gynecol Obstet Invest 1994;37:48-51.
14. Rechberger T, Donica H, Baranowski W, Jakowicki J. Female urinary stress incontinence in terms of connective tissue biochemistry. Eur J Obstet Gynecol Reprod Biol 1993;49:187-91.
15. Liapis A, Bakas P, Pafiti A, Hassiakos D, Frangos-Plemenos M, Creatsas G. Changes in the quantity of collagen type I in women with genuine stress incontinence. Urol Res 2000;28:323-6.
16. Ulmsten U, Ekman G, Giertz G, Malmstrom A. Different bio-chemical composition of connective tissue in continent and stress incontinent women. Acta Obstet Gynecol Scand 1987;66:435-7.
17. Keane DP, Sims TJ, Abrams P, Bailey AJ. Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 1997;104:994-8.
18. Zhang J, Salamonsen LA. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 2002;87:2346-31.
19. Yoshida K, Tahara R, Nakayama T, Yanaihara T. Effect of dehydroepiandrosterone sulphate, oestrogens and prostaglandins on collagen metabolism in human cervical tissue in relation to cervical ripening. J Int Med Res 1993;21:26-35.
20. Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987;70:123-7.
21. Gomez DE, Alonso DF, Yoshiji J, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-22.
22. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J 2002;13:80-7.
23. Sato T, Ito A, Mori Y, Yamashita K, Hayakawa T, Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts: modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J 1991;275:645-50.
24. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, et al. The matrix metalloproteinase-1 (MMP-1) expression in the human endometrium is inversely regulated by interleukin-1 alpha and sex steroids. Ceska Gynekol 2000;65:211-5.
25. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999;99:2503-9.
26. Langman J. Medical embryology. Baltimore: Williams & Wilkins; 1969. p. 149-62.
27. Keane DP, Sims TJ, Bailey AJ, Abrams P. Analysis of pelvic floor electromyography and collagen status in pre-menopausal nulliparous females with genuine stress incontinence (GSI). Neurourol Urodyn 1992;11:308-9.